Because we did not measure DAS28 scores in the DMARD cohort at 6 months, we cannot determine whether reduction in RA disease activity secondary to any treatment is associated with a reduction in MI incidence, or whether this finding is specific to anti-TNFα therapy. Here, TNF is linked to rheumatoid arthritis.